← Back
$AVTX All transactions

Avalo Therapeutics, Inc.

A

$ Value

$17K

Shares

1,370

Price

$12

Filed

Apr 1

Insider

Name

Lind Kevin Robert

Title

CIK

0001677036

Roles

Director

Transaction Details

Transaction Date

2026-03-31

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

1,370

Footnotes

The options were granted on March 31, 2026, and are 100% vested.

Filing Info

Accession No.

0001677036-26-000002

Form Type

4

Issuer CIK

0001534120

Lind Kevin Robert's History

Date Ticker Type Value
2026-03-31 AVTX A $17K
2025-10-01 AVTX A $0

Other Insiders at AVTX (90d)

Insider Bought Sold Last
KAPLAN GILLA 2026-03-28
NEIL GARRY ARTHUR
Chief Executive Officer
2026-03-28
Jain Rita 2026-03-31
Chan Mitchell 2026-03-28
Sullivan Christopher Ryan
Chief Financial Officer
$271K 2026-04-02
KANTOFF AARON 2026-03-28
Doyle Mittie
Chief Medical Officer
$82K 2026-04-06
Goldman Jonathan 2026-03-28
Truex Samantha 2026-03-28